N.N. Blokhin NMRCO ( Site 1000)

Moscow, Moscow 115478

0 studies enrolling now · 1 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer

Studies at this site

• A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) — Completed